首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.
【2h】

Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.

机译:β-抑制蛋白和抑制蛋白被多发性硬化症患者血清中的自身抗体识别。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple sclerosis (MS), one of the most common chronic neurologic diseases, is characterized by the presence of multiple plaques of demyelination throughout the central nervous system. Although the etiology of the disease has not been established, it is believed to involve autoimmune mechanisms. We have examined sera from patients with MS for the presence of antibodies to antigens from brain and retina. Immunoblot analysis of soluble fraction of proteins from bovine brain revealed a prominent band at 45 kDa stained with sera of 8-14 patients with MS. In two patients with MS, serum antibody titers during relapse were higher compared with those when the patients were in remission. These antibodies were undetectable in cerebrospinal fluid of our MS patients and additionally were absent in sera of patients with other neurological diseases and normal control subjects. Furthermore, immunoblot analysis of the soluble fraction from bovine retinal rod outer segments revealed a prominent protein band at 48 kDa stained with MS sera. This antigen was purified to homogeneity from bovine retinal outer segments and identified as arrestin. Additionally, sera from MS patients reacted with purified beta-arrestin 1, a 45-kDa protein homologous to arrestin that is found in various tissues. Using limited proteolysis of arrestin and a competitive ELISA test with a synthetic peptide, we identified the recognition site(s) for antibodies in sera of MS patients at a dominant immunogenic site on arrestin located at the C-terminal region of the molecule. We suggest that the presence of circulating antibodies reactive with beta-arrestin or arrestin may be related to the course of MS progression.
机译:多发性硬化症(MS)是最常见的慢性神经系统疾病之一,其特征是在整个中枢神经系统中存在多处脱髓鞘斑。尽管尚未确定疾病的病因,但据信其涉及自身免疫机制。我们检查了患有MS的患者的血清中是否存在针对大脑和视网膜抗原的抗体。牛脑蛋白质可溶性部分的免疫印迹分析显示,在45 kDa处有一条显着的条带,被8-14例MS患者的血清染色。在两名MS患者中,与缓解期患者相比,复发期间的血清抗体滴度更高。这些抗体在我们的MS患者的脑脊液中无法检测到,此外在患有其他神经系统疾病的患者和正常对照组的患者血清中也没有。此外,对来自牛视网膜棒外部区段的可溶性部分的免疫印迹分析显示,用MS血清染色的48 kDa处有一条突出的蛋白带。该抗原从牛视网膜外段纯化至同质并鉴定为抑制素。此外,来自MS患者的血清与纯化的β-arrestin1反应,β-arrestin1是一种45 kDa蛋白,与在各种组织中发现的抑制蛋白同源。使用抑制蛋白的有限蛋白水解和具有合成肽的竞争性ELISA试验,我们在分子C端区域中抑制蛋白的主要免疫原性位点上,鉴定了MS患者血清中抗体的识别位点。我们建议与β-arrestin或arrestin反应的循环抗体的存在可能与MS进展的过程有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号